Maastricht University, Netherlands
Chujie Li, a PhD student at Maastricht University in the Netherlands, specializes in anticancer pharmacology. Her research focuses on the development and evaluation of novel therapeutic agents in cancer treatment, particularly in combination strategies. Her recent studies explored strategies to widen the radiotherapy therapeutic window, with the aim of sensitizing tumors to treatment while preventing radiation-induced damage to normal tissues.
Poster Presentation (In-Person)
Title: monoHER as a selective radiosensitizer in breast cancer
Copyright 2024 Mathews International LLC All Rights Reserved